| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 19 |
| 1 | EVEROLIMUS | 19 |
| 2 | CYCLOPHOSPHAMIDE | 17 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 17 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 17 |
| 5 | OCTREOTIDE ACETATE | 15 |
| 6 | CAPECITABINE | 14 |
| 7 | PACLITAXEL | 14 |
| 8 | TRASTUZUMAB | 14 |
| 9 | CARBOPLATIN | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GRISEOFULVIN | 1 | 0.0034 |
| 1 | TOPOTECAN | 7 | 0.0011 |
| 2 | SODIUM IODIDE I 123 | 1 | 0.0011 |
| 3 | SODIUM IODIDE I 131 | 1 | 0.0010 |
| 4 | DACTINOMYCIN | 2 | 0.0009 |
| 5 | RILONACEPT | 1 | 0.0009 |
| 6 | BRIGATINIB | 3 | 0.0008 |
| 7 | TOPOTECAN HYDROCHLORIDE | 2 | 0.0008 |
| 8 | DOSTARLIMAB | 2 | 0.0008 |
| 9 | CLINDAMYCIN PHOSPHATE | 4 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 48 |
| 1 | Corticosteroid [EPC] | 30 |
| 2 | Alkylating Drug [EPC] | 26 |
| 3 | Aromatase Inhibitor [EPC] | 24 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 24 |
| 5 | Platinum-based Drug [EPC] | 23 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 23 |
| 7 | Microtubule Inhibitor [EPC] | 22 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 21 |
| 9 | mTOR Inhibitor Immunosuppressant [EPC] | 20 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tubulin Inhibiting Agent [EPC] | 1 | 0.0034 |
| 1 | Actinomycin [EPC] | 2 | 0.0009 |
| 2 | Somatostatin Analog [EPC] | 3 | 0.0004 |
| 3 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 4 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 5 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 6 | Aromatase Inhibitor [EPC] | 24 | 0.0002 |
| 7 | Topoisomerase Inhibitor [EPC] | 15 | 0.0002 |
| 8 | HER2/neu Receptor Antagonist [EPC] | 14 | 0.0002 |
| 9 | Nitroimidazole Antimicrobial [EPC] | 11 | 0.0002 |